Journal of Patient-Centered
Research and Reviews
Volume 6

Issue 3

Article 4

7-29-2019

Relationship of Patient Self-Administered COPD Assessment Test
to Physician Standard Assessment of Chronic Obstructive
Pulmonary Disease in a Family Medicine Residency Training
Program
Jessica E. Burchette
Ivy A. Click
Leigh Johnson
S. Alicia Williams
Brett Tyler Morgan

Follow this and additional works at: https://aah.org/jpcrr
Part of the Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons,
Cardiovascular Diseases Commons, Family Medicine Commons, Medical Education Commons,
Pulmonology Commons, and the Respiratory Tract Diseases Commons

Recommended Citation
Burchette JE, Click IA, Johnson L, Williams SA, Morgan BT. Relationship of patient self-administered
COPD Assessment Test to physician standard assessment of chronic obstructive pulmonary disease in a
family medicine residency training program. J Patient Cent Res Rev. 2019;6:210-5. doi: 10.17294/
2330-0698.1699

Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the
Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal
focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes,
and the patient experience.

BRIEF REPORT

Relationship of Patient Self-Administered COPD
Assessment Test to Physician Standard Assessment
of Chronic Obstructive Pulmonary Disease in a Family
Medicine Residency Training Program
Jessica E. Burchette, PharmD,1 Ivy A. Click, EdD,2 Leigh Johnson, MD,2 S. Alicia Williams, MA,2
Brett Tyler Morgan, MA2
Department of Pharmacy Practice, Bill Gatton College of Pharmacy, East Tennessee State University, Johnson City, TN;
Department of Family Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN

1
2

Abstract	Assessing the global impact of chronic obstructive pulmonary disease (COPD) on a patient’s life
can be difficult to perform in the clinical setting due to time constraints and workflow challenges.
The primary objective of this study was to compare disease impact ratings between patient selfadministered COPD Assessment Test (CAT) and physician standard office assessment. This
prospective study was conducted at a family medicine residency clinic in northeast Tennessee. The
study included two study groups: 1) adult patients seen at the clinic during the 3-month study period
with an active diagnosis of COPD, and 2) their physicians. Physicians’ assessment of the impact of
COPD on their patients’ daily lives was compared to patients’ self-administered CAT assessments.
Physician assessment of COPD impact and patient assessment of CAT categories significantly
differed (χ2=11.0, P=0.012). There was very poor agreement between patient and physician ratings
(κ=0.003), with 42.9% of physician ratings underestimating the impact, 28.6% overestimating the
impact, and 28.6% correctly estimating the impact COPD had on their patients’ lives. These findings
support the use of validated assessment tools to help providers understand the symptom burden for
patients with COPD. (J Patient Cent Res Rev. 2019;6:210-215.)
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A

n estimated 11 million Americans have a
diagnosis of chronic obstructive pulmonary
disease (COPD), with another 13 million
potentially affected.1,2 Currently, COPD is ranked as
the third-leading cause of death in the United States.3
Certain geographical regions are more impacted by
COPD due in part to cultural influences and lifestyle
factors such as smoking and occupational exposure.
Tennessee has one of the higher percentages of citizens
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diagnosed with COPD, with a current prevalence
estimate of 8.1% (state range: 3.5%–13.6%).1
Symptoms of COPD are highly variable with
significantly different presentations between
patients.4,5 Hallmark symptoms of shortness of
breath and increased sputum production can often
overshadow nonspecific symptoms, which may be
overlooked or not attributed to COPD. Anxiety,
depression, and difficulty sleeping are often present
but may not be correlated to COPD by patients
or providers.6 These symptoms can be difficult to
measure and often affect activities of daily living as
well as confidence in simple tasks such as leaving the
home without fear of worsened symptoms.7
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Assessing the global impact of COPD on an individual
patient can be difficult to perform because of time
constraints and workflow challenges in clinic.8 Also,
patients may underreport the severity of COPD during
standard patient-provider interactions due to the
variability of symptoms over time.9 Given that ample
data have indicated that spirometry does not directly
correlate with symptoms,10 the need for a reliable
assessment tool to measure disease impact is crucial.
Family medicine providers care for a complex
and diverse patient population with many chronic
diseases. Utilizing a standard assessment to guide
the patient discussion can assist providers in
formulating evidence-based care plans for individual
patients. These assessments can open discussion
regarding disease impact on quality of life beyond a
generic “How are you?” approach.11 Understanding
and valuing which aspects of a disease are most
concerning to patients is a cornerstone of patientcentered care and has an influence on patient-provider
trust and rapport.12
The COPD Assessment Test (CAT) was developed in
2009 as a short, patient-administered questionnaire for
measuring health-related quality of life for patients with
COPD.13 This assessment was designed for clinical
practice, taking about 2 to 3 minutes to complete,
and has been validated in multiple languages.14 Ideally,
patients would self-administer the CAT prior to an office
visit as a tool for stimulating discussion. Scores range
from 0 to 40 and are categorized as low, medium, high,
or very high impact. The CAT is currently undergoing
review by an expert governance board to ensure
usability and reliability for patients everywhere.15
The primary objective of this study was to compare
disease impact ratings between patient self-administered
CAT and physician standard office assessment.
Secondary objectives include whether patient and/or
physician characteristics impacted COPD assessment
scoring variations between the two groups.

METHODS

This prospective study was conducted at a family
medicine residency clinic in northeast Tennessee.
The study included two groups: 1) adult patients seen
at the clinic during the 3-month study period with an

Brief Report

active ICD-10 code consistent with COPD, and 2)
their physicians. This study was approved by the East
Tennessee State University institutional review board.
Informed consent was obtained from all participants.
The clinic’s social health specialist reviewed a weekly
report of scheduled appointments and assessed for the
following inclusion criteria: age of ≥18 years, active
diagnosis of COPD, English speaking, legally able to
make personal treatment decisions, and not pregnant at
the time of the visit. Those with an acute exacerbation
of COPD within 2 weeks of the visit were excluded.
Potential patients were highlighted each day prior to
the start of clinic. All clinic physicians were eligible
for inclusion.
Upon completion of the visit, physicians completed
a 1-item assessment of their perception of whether
COPD had a low, medium, high, or very high impact
on their patient’s quality of life (mimicking CAT
impact categories). Physician gender and experience
level (resident training year, faculty) were collected.
Eligible patients were approached by the nurse before
leaving the examination room to ask about willingness
to participate. Those willing to participate were
escorted to the social health specialist’s office, where
they were consented and asked to complete the CAT.
Patient demographics, including age, gender, and
smoking status, were collected. Figure 1 illustrates the
study workflow.
Descriptive analyses were used to provide summaries
of patient and physician participant demographic
characteristics. Patient participants’ CAT scores
were totaled and categorized by impact on wellbeing and daily life (low, medium, high, or very high
impact). Chi-squared (χ2) tests were used to compare
physicians’ ratings of COPD impact to their patients’
CAT categories, as well as differences in sex, smoking
status, and physician experience. Cohen’s kappa (κ)
coefficient was used to compare agreement between
physician and patient ratings. All analyses were
conducted using SPSS Statistics, Version 23 (IBM
Corp, Armonk, NY).

RESULTS

Fifty matched pairs of patient CAT and physician
assessment forms were collected over 3 months. One
set was removed due to incomplete data, leaving 49
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Study staff confirm
list of eligible
patients each week

Nurses notified of
eligible patients at
morning huddle
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Patient consented
in private office by
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Patient completes
COPD Assessment
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Figure 1. Chronic obstructive pulmonary disease
(COPD) assessment study flow.

usable sets of matched forms. The majority of the 49
patient participants were female (61.2%), and the cohort
averaged 63.5 ± 8.9 years of age. Slightly more than
half were current smokers (51%). Physician participants
were more frequently male (55.1%) and third-year
family medicine residents (40.8%) (Table 1).
There were significant differences between physician
assessment of COPD impact on patients’ lives
and patients’ self-assessment of CAT categories
(χ2=11.0, P=0.012) (Figure 2). Data indicated very
poor agreement between patient and physician
ratings (κ=0.003), with 42.9% of physician ratings
underestimating the impact, 28.6% overestimating
the impact, and 28.6% correctly estimating the impact
COPD had on their patients’ lives. Furthermore,
physicians were more likely to underestimate COPD
impact for those not currently smoking (50%) versus
current smokers (36.0%); P=0.047. Although female
physicians were more likely to correctly assess COPD
impact (40.9%) than male physicians (18.5%), this was
not statistically significant (P=0.08). There were no
significant differences based on physician experience,
patient sex, or patient age.
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DISCUSSION

Implementing a standardized, validated assessment tool
to monitor chronic disease impact has value for patients
and providers.9 Our study identified a discrepancy
between physician assessment of disease impact and
patient self-reported impact via CAT scoring. One
explanation for this incongruity is a lack of general
knowledge among physicians and patients of less welldescribed COPD symptoms. Most patients understand
that shortness of breath, coughing, and sputum production
are symptoms of COPD; however, other symptoms such
as anxiety, depression, or poor sleep patterns may not
be considered COPD-related. Patients with COPD have
been shown to experience a higher mental health burden
than patients with other chronic health conditions, and
the correlation between COPD and mental health has
been linked to negative effects on mortality, increased
risk of exacerbations, longer hospital stays, and poorer
quality of life with decreased functional status.16,17
During a general patient encounter, the patient may
not report psychological symptoms when asked about
the impact of COPD on daily life because of a lack of
knowledge related to symptom-disease relationship.18
Clinically, there are significant implications for patients
to underestimating the impact of COPD, including
potential undertreatment of symptoms that could lead to
acute exacerbations, further decreasing quality of life.
Another potentiating factor in the patient-provider
disease assessment may be variation between individual
providers related to COPD assessment. For example,
female physicians are more likely to engage in patientcentered communication,19,20 suggesting that perhaps
they are better poised to estimate individual patient
disease impact. The increased correct assessment of
COPD impact by female physicians was not statistically
significant in this pilot study, perhaps due to sample
size. Nonetheless, as each provider has his or her own
style of patient interview, the assessment of disease may
vary based on the types of questions asked and the way
in which they are posed to the patient. By implementing
a standardized assessment for COPD impact, patients
and providers can come to the encounter with common
ground for assessment and discussion.
The clinical impact of adding a standardized assessment
of COPD, such as the CAT, to routine care for all
patients with COPD does not come without added
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Table 1. Characteristics of Patients (n=49) and Physicians (n=49) and Their Respective Relationships to
COPD Impact Agreement

Physician Agreement With Patient CAT
Characteristic

All,
n (%)

COPD impact

Same,
n (%)

Under,
n (%)

Over,
n (%)

P

14 (28.6)

21 (42.9)

14 (28.6)

0.01

Patient age*
45–54 years
55–64 years
65–74 years
75–84 years

10 (20.4)
14 (28.6)
20 (40.8)
5 (10.2)

5 (50.0)
3 (21.4)
4 (20.0)
2 (40.0)

4 (40.0)
5 (35.7)
11 (55.0)
1 (20.0)

1 (10.0)
6 (42.9)
5 (25.0)
2 (40.0)

0.36

Patient sex
Female
Male

30 (61.2)
19 (38.8)

7 (23.3)
7 (36.8)

14 (46.7)
7 (36.8)

9 (30.0)
5 (26.3)

0.31

Physician sex
Female
Male

22 (44.9)
27 (55.1)

9 (40.9)
5 (18.5)

8 (36.4)
13 (48.1)

5 (22.7)
9 (33.3)

0.08

Patient smoking status
Current smoker
Former smoker

25 (51.0)
24 (49.0)

11 (44.0)
3 (12.5)

9 (36.0)
12 (50.0)

5 (20.0)
9 (37.5)

0.05

Physician training year
PGY 1
PGY 2
PGY 3
Faculty

8 (16.3)
18 (36.7)
20 (40.8)
3 (6.1)

2 (25.0)
8 (44.4)
4 (20.0)
0 (0.0)

4 (50.0)
6 (33.3)
10 (50.0)
1 (33.3)

2 (25.0)
4 (22.2)
6 (30.0)
2 (66.7)

0.47

*Mean age for the 49-patient cohort was 63.5 ± 8.9 years.
CAT, COPD Assessment Test; COPD, chronic obstructive pulmonary disease; PGY, postgraduate year.

time requirements for clinical workflow. Practice
administrators should evaluate current procedures to
determine appropriate places within the patient/clinic
flow to administer these assessments. Patient checkin is an easily identifiable point in clinic workflow to
administer an assessment; this procedure would allow
patients to complete the assessment prior to seeing
the provider and may prompt patients to generate
questions regarding their care. To avoid the potential
of biasing the study, our patients did not complete the
CAT prior to seeing the provider, but in daily practice
asking a patient to complete the CAT prior to the
visit would likely be more beneficial to the patientprovider discussion.14 Alternatively, asking the nurse
to provide the CAT to the patient as they are roomed
could provide more information during the encounter
without disrupting clinic flow.
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This study has many strengths, which support the
validity of the results in practice. The study was a
prospective review of real-time provider assessment of
COPD impact on a patient’s life. The providers were
instructed to perform their assessment and exam as
usual and had not been previously educated on the CAT.
Patient self-assessment of disease impact via the CAT
is validated in the literature and proven to increase the
comprehensiveness of patient symptom reporting.9,21
Having patients complete the CAT after the encounter
prevented discussion of the questions and results with the
provider during the visit, helping to reduce study bias.
Although efforts were taken to solidify and strengthen
this study, there are limitations that should be
addressed. Due to patient identification methods
and variation in monthly resident schedules, we were
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Figure 2. Comparison of patient COPD Assessment Test categories and physician assessment of chronic
obstructive pulmonary disease (COPD) on well-being and daily life.

unable to assess the level of provider/patient continuity
of care. Arguably, a lack of familiarity with the patient
may have impacted the provider’s ability to assess
disease impact. Another limitation is the difference in
assessment methods for comparing patient and provider
results. Physicians were asked to categorize patients
directly into 1 of 4 impact categories, whereas patient
CAT scores were represented numerically as the sum of
the 8-item Likert scale assessment and then categorized
by impact. This difference in scoring could have created
discrepancy between the provider and patient scoring.
Finally, although we made multiple efforts to reduce
study bias, it is possible physicians may have been
alerted to a potential study participant prior to seeing
the patient, which could have triggered the physician
to ask additional COPD-related questions. However,
even with this potential bias, we still found physicians
underestimated the impact of COPD on patients’ lives.
Future plans include assessing the effect of fully
implementing the CAT into practice and the impact
on treatment decisions. As addressed previously, there
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are no available data addressing variation among
provider styles. Future work that attempts to quantify
and qualify provider style differences may further
contribute to the development of reliable standardized
patient assessments. Much of the future direction
regarding the widespread use of the CAT within the
United States will depend on the outcomes from the
CAT governance board.15
Our results indicated poor agreement between
physicians’ standard assessment of COPD symptom
impact on patients’ daily lives and patients’ selfassessment. These findings support the use of validated
assessment tools to help providers understand the
symptom burden for patients with COPD. Family
medicine providers are uniquely positioned to care for
patients with many chronic diseases, which includes
understanding the patients’ perspective on disease and
the symptom burden impacting daily life. Standardized
measures of disease impact, such as the CAT, have
value for both patients and providers in daily practice
and can be an important tool in creating a dialogue
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between provider and patient. This study serves as
an important pilot identifying a potential area for
improvement in patient-provider communication in
any clinic caring for patients with COPD.

Patient-Friendly Recap
• Chronic obstructive pulmonary disease, or
COPD, can be a deadly condition but also
results in a range of serious symptoms that
negatively affect patients’ lives.
• The authors compared the responses of
patients to questions on a COPD selfassessment test with those of the patients’
physicians in a clinical setting.
• They found that physicians often underestimate
the presence of COPD symptoms and the
disease’s impact on patients’ quality of life.
• This discrepancy may be, in part, due to
patients not realizing certain symptoms, like
anxiety or poor sleep, can be related to COPD
and should be reported as such.
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